Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Sousa (Aveiro, Portugal), S. Melo-Dias (Aveiro, Portugal), C. Valente (Aveiro, Portugal), L. Andrade (Aveiro, Portugal), A. Marques (Aveiro, Portugal). Saliva as a “patient-friendly” specimen for COPD assessment. 676

Member's Comments

No comment yet.

Related content which might interest you: Sputum biospecimen quality and suitability for microbiome characterisation in COPD Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease Year: 2018 Using routine spirometry to obtain sputum samples in the respiratory clinic Source: Annual Congress 2011 - Update on monitoring airway diseases Year: 2011 Bronchial biopsy can not be recommended to discriminate asthma and COPD in routine practice Source: Eur Respir J 2003; 22: Suppl. 45, 413s Year: 2003 Bronchoscopy and bronchial biopsy are safe and useful procedures in the evaluation of severe uncontrolled asthma Source: International Congress 2019 – Long-term evaluation and control of airway diseases Year: 2019 Blood biomarker algorithms to guide COPD assessment and risk stratification Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes Year: 2017 Are FENO indices useful diagnostic tools in suspected asthma? Experience of a routine lung function laboratory Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Quality of automated sputum cytometry specimen in asthma Source: Eur Respir J 2001; 18: Suppl. 33, 164s Year: 2001 Sputum induction in asthmatic children: safety in children and feasibility of new methods of monitoring inflammation in sputum samples Source: Eur Respir J 2006; 28: Suppl. 50, 259s Year: 2006 Clinical use of induced sputum in the management of asthma. A noninvasive measurements of airway Source: Annual Congress 2007 - Assessing asthma severity and control in children Year: 2007 A proposal for standardization of the bronchial biopsy assessment in severe asthma Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 Skin integrity in domiciliary non-invasive ventilation: a clinical audit Source: International Congress 2018 – Non-invasive ventilation in chronic respiratory failure Year: 2018 Peak cough flow via tracheostomy – A useful assessment tool before decannulation? Source: Annual Congress 2013 –Assessment methods involved in the physiotherapy treatment in different patient populations Year: 2013 Preference of the inhaler device and assessment of the technique among the asthmatic and COPD patients Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II Year: 2011 Nasal cytology analysis in stable COPD patients Source: International Congress 2019 – Research and innovation in airway diseases Year: 2019 The value of obtaining brushing samples in addition to biopsy and washings in the diagnosis of lung cancer Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Telemedicine as a valuable tool in home monitoring of COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 65s Year: 2004 How can we improve our assessment of inflammation in clinical studies of COPD that use bronchial biopsies? Source: Eur Respir J 2006; 27: 248-249 Year: 2006 An Investigation into the ability of people with lung disease to provide breath specimens using a roadside screening device and an evidential breath testing device. Source: International Congress 2017 – Lung function testing Year: 2017 Sputum biomarkers in stable COPD Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 An electronic nose in the diagnostic assessment of asthma in pediatric patients Source: Annual Congress 2007 - Noninvasive evaluation of airway diseases Year: 2007